Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 28: 1297-1302, 1982;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Werner, M.
Right arrow Articles by Wasserman, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Werner, M.
Right arrow Articles by Wasserman, A. G.

Clinical Chemistry, Vol 28, 1297-1302, Copyright © 1982 by American Association for Clinical Chemistry

Diagnostic performance of enzymes in the discrimination of myocardial infarction

M Werner, SH Brooks, RJ Mohrbacher and AG Wasserman

We apply rigorous statistical methods to assess the diagnostic value of creatine kinase, creatine kinase-MB, aspartate aminotransferase, lactate dehydrogenase, and alpha-hydroxybutyrate dehydrogenase in realistic circumstances. The trade-off between false positives and false negatives obtained with various decision rules is examined with the receiver-operator characteristic function and with discriminant analysis. During the three days after an infarction, lactate and alpha- hydroxybutyrate dehydrogenase can provide diagnostic thresholds of constant sensitivity and specificity. By contrast, sensitivity progressively decays for creatine kinase, creatine kinase-MB, and aspartate aminotransferase. The diagnostic uncertainty introduced by the infarction's varying age at hospitalization is evaluated by subjecting the mixed patient population to discriminant analysis. For some enzymes, repeating the same assay on the second day contributes to sensitivity, while adding a different assay on the first day enhances specificity. The effects of lower or higher infarction prevalences on sensitivity and specificity are most favorable when creatine kinase-MB is combined with lactate or alpha-hydroxybutyrate dehydrogenase. Adding a third assay is ineffective. The further differentiation according to infarction stage produces only 81% correct classifications, even when five different assays are used on two consecutive days. As a general strategy, we recommend the assay of two enzymes on two consecutive days.


The following articles in journals at HighWire Press have cited this article:


Home page
 HeartHome page
P O Collinson, P J Stubbs, and A-C Kessler
Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice
Heart, March 1, 2003; 89(3): 280 - 286.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Association for Clinical Chemistry.